Studies which are potentially eligible for consideration for NIHR Clinical Research Network support are those that are:
- Commercially funded and commercially sponsored (i.e. commercial contract research)
- Non-commercial studies
o Investigator initiated trials (i.e. commercial collaborative research)
o Funded by overseas Governments
o Funded by overseas charities
Adoption process
All potentially eligible studies are considered for eligibility for Clinical Research Network support via an adoption process.
Commercially funded, commercially sponsored studies
Industry sponsored studies that have been reviewed by a Network Industry Adoption Panel and accepted into the NIHR CRN Portfolio will be classed as high priority.
Find out more about the industry adoption process
The Industry contact at the relevant Network Coordinating Centre will act as the first point of contact. The company leads the submission for the adoption of their study.
Contact the Clinical Research Network industry team
Non-commercial studies
Non-commercial studies that require adoption are either:
- Initiated by non-commercial investigators (e.g. University or NHS staff) with the majority of the research funding being provided by a commercial organisation (e.g. a pharmaceutical, biotechnology or devices company) specifically to support that study
- Funded by overseas Governments
- Funded by overseas charities
These studies must be considered via the non-commercial adoption process to ensure the quality of the studies and their value to the NHS prior to confirmation of eligibility for consideration for NIHR Clinical Research Network support. If eligible, these studies will be given a medium priority (IITs and overseas Governments) or low priority (overseas charities) for Clinical Research Network support.
The non-commercial adoption process involves review by subject specific experts against specific criteria focused on:
- Clear value to the NHS
- Ensuring the study takes account of the priorities, needs and realities of the NHS
